4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-043653
SVP-Chief Financial Officer bought 10,000 shares at $9.80 ($98,000)
From the SEC's structured data for this filing
Trades in this filing
Maxwell John T. · SVP-Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-21 | Purchase : show line 1 in the form | +10,000 | $9.80 | $98,000 | 148,614 | D |
| Open-market purchases · 10,000 sh · avg $9.80 · $98,000 | ||||||
Loading xslF345X03/form4.xml…